Clinical Trial Update: Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery [NA]

View source ↗

Summary

An update on a clinical trial comparing endhole versus pressure-modulated Lipiodol delivery for hepatocellular carcinoma and neuroendocrine tumors; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Neuroendocrine Tumors

Drugs mentioned

• Lipiodol (Ethiodized oil)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Hepatocellular Carcinoma, Neuroendocrine Tumors | NA | Status: ACTIVE_NOT_RECRUITING